MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Theravance Biopharma Company Profile (NASDAQ:TBPH)

Consensus Ratings for Theravance Biopharma (NASDAQ:TBPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $14.00 (4.18% downside)

Analysts' Ratings History for Theravance Biopharma (NASDAQ:TBPH)
Show:
DateFirmActionRatingPrice TargetActions
8/11/2015Robert W. BairdReiterated RatingNeutral$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015Robert W. BairdUpgradeUnderperform -> Neutral$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014Robert W. BairdDowngradeNeutral -> Underperform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2014Bank of AmericaInitiated CoverageBuy$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Robert W. BairdInitiated CoverageNeutral$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/29/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha